These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 19535387)

  • 1. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
    Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
    Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
    Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
    J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
    Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
    BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A; Gravani K; Karameris A; Kombouras C
    J Surg Res; 2008 Jun; 147(1):99-107. PubMed ID: 17655863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
    Chung GG; Yoon HH; Zerkowski MP; Ghosh S; Thomas L; Harigopal M; Charette LA; Salem RR; Camp RL; Rimm DL; Burtness BA
    Cancer; 2006 Apr; 106(8):1677-84. PubMed ID: 16532435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer.
    Hirashima Y; Yamada Y; Matsubara J; Takahari D; Okita N; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Cancer Sci; 2009 Feb; 100(2):310-5. PubMed ID: 19068081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
    Fan YZ; Li GM; Huang GP; Li XP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer.
    Noike T; Miwa S; Soeda J; Kobayashi A; Miyagawa S
    Hum Pathol; 2008 Feb; 39(2):201-8. PubMed ID: 17949784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
    Sha D; He YJ
    Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Chlouverakis G; Vourvouhaki E; Turley H; Harris AL; Gatter KC
    Eur J Clin Invest; 2007 Nov; 37(11):878-86. PubMed ID: 17883421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.
    Bendardaf R; Buhmeida A; Hilska M; Laato M; Syrjänen S; Syrjänen K; Collan Y; Pyrhönen S
    Anticancer Res; 2008; 28(6B):3865-70. PubMed ID: 19192642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
    Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
    Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.